DGAP-News

amp biosimilars AG appoints Professor Dr. Dr. Rolf G. Werner as chairman of the Scientific Board - Seite 2

global populace the means for improved quality of life, and I am happy to
be able to help in this regard," says Professor Werner, Honorary Senator at
the University of Tübingen.

The Scientific Board at amp biosimilars AG is currently composed of three
members and supports management with the implementation of its global
biosimilar development and commercialization strategy. In addition to its
chairman, Prof. Werner, the Scientific Board includes Dr. Holger Ziehr and
Dr. Xavier Luria. Dr. Ziehr, head of the Department of Pharmaceutical
Biotechnology at the ITEM Fraunhofer Institute, has previously developed
numerous biosimilars such as EPO, G-CSF and ß-interferon until the GMP
production. Dr. Luria has been the Head of Safety and Efficacy of Medicines
at the European Medicines Agency (EMA), where he coordinated international
Teams from the 28 EU member states in the regulatory evaluation of medical
products.

About amp biosimilars AG:
amp biosimilars AG develops high quality biosimilars to meet growing demand
on global therapeutic markets and is one of the most innovative and dynamic
biosimilar companies in Europe. The company is headquartered in Hamburg and
run by a team of leading industry experts. The development of a wide
variety of biosimilars will provide patients around the world with access
to life-improving and life-saving therapies. The combination of a research
platform with state-of-the-art analytics, process technology and clinical
expertise as well as regulatory know-how, makes amp biosimilars AG one of
the leading companies for biosimilar development and marketing. Thanks to
an international network of leading pharmaceutical companies, amp
biosimilars AG also has direct access to the strongest growing markets in
the world. With this approach amp biosimilars AG has a key position in one
of the fastest growing life science markets in the near future. amp
biosimilars AG has been listed on the Munich Stock Exchange since April 1,
2015. For more information please go to www.ampbiosimilars.com

Contact:
MC Services AG
Fabian Lorenz
T [phone]
Email: [e-mail]



---------------------------------------------------------------------

28.04.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


349293 28.04.2015